AMPK activation suppresses cancer stem cells by preventing prenylation of the mevalonate pathway proteinsAMPK activation and elevated levels of ROS together suppress the mTOR pathway and its downstream targets P70S6K and 4EBP1. This evidence concerns the gene PRKAA2 and cancer.